{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T01:17:05Z","timestamp":1790299025269,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","schres-journal.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.schres.2015.05.004","type":"journal-article","created":{"date-parts":[[2015,5,21]],"date-time":"2015-05-21T17:11:05Z","timestamp":1432228265000},"page":"201-206","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":79,"title":["Metabolic syndrome in drug-na\u00efve and drug-free patients with schizophrenia and in their siblings"],"prefix":"10.1016","volume":"166","author":[{"given":"Asl\u0131","family":"Enez Darcin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sercin","family":"Yalcin Cavus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nesrin","family":"Dilbaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasan","family":"Kaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eylem","family":"Dogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2015.05.004_bb0070","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","volume":"285","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.schres.2015.05.004_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2008.05.009","article-title":"A comparison of schizophrenia outpatients treated with antipsychotics with and without metabolic syndrome: Findings from the CLAMORS study","volume":"104","author":"Arango","year":"2008","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2015.05.004_bb0010","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.schres.2010.10.014","article-title":"The metabolic syndrome and its constituting variables in atypical antipsychotic-treated subjects: Comparison with other drug treatments, drug-free psychiatric patients, first-degree relatives and the general population in Venezuela","volume":"126","author":"Baptista","year":"2007","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2015.05.004_bb0015","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0920-9964(92)90040-C","article-title":"Mortality in DSM-III-R schizophrenia","volume":"7","author":"Black","year":"1992","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2015.05.004_bb0025","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1192\/bjp.171.6.502","article-title":"Excess mortality of schizophrenia: a meta-analysis","volume":"171","author":"Brown","year":"1997","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.schres.2015.05.004_bb0020","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1192\/bjp.177.3.212","article-title":"Causes of the excess mortality of schizophrenia","volume":"177","author":"Brown","year":"2000","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.schres.2015.05.004_bb0030","first-page":"124","article-title":"The prevalence of metabolic syndrome and related factors in patients with schizophrenia","volume":"19","author":"Cerit","year":"2008","journal-title":"Turk. J. Psychiatry"},{"key":"10.1016\/j.schres.2015.05.004_bb0035","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1177\/070674370605100608","article-title":"Insulin resistance and adiponectin levels in drug-free patients with schizophrenia: a preliminary report","volume":"51","author":"Cohn","year":"2006","journal-title":"Can. J. Psychiatry"},{"key":"10.1016\/j.schres.2015.05.004_bb0040","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.schres.2006.08.017","article-title":"Does antipsychotic polypharmacy increase the risk for metabolic syndrome?","volume":"89","author":"Correll","year":"2007","journal-title":"Schizophr. Res."},{"issue":"5","key":"10.1016\/j.schres.2015.05.004_bb0045","doi-asserted-by":"crossref","first-page":"715","DOI":"10.4088\/JCP.v65n0519","article-title":"Cardiovascular disease in patients with schizophrenia in Saskatchewan, Canada","volume":"65","author":"Curkendall","year":"2004","journal-title":"J. Clin. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2015.05.004_bb0065","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.schres.2005.12.855","article-title":"Prevalence of the metabolic syndrome in patients with schizophrenia treated with antipsychotic medication","volume":"83","author":"De Hert","year":"2006","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2015.05.004_bb0060","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1745-0179-2-14","article-title":"Prevalence of diabetes, metabolic syndrome and metabolic abnormalities in schizophrenia over the course of the illness: a cross-sectional study","volume":"2","author":"De Hert","year":"2006","journal-title":"Clin. Pract. Epidemiol. Ment. Health"},{"issue":"1","key":"10.1016\/j.schres.2015.05.004_bb0055","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/j.2051-5545.2009.tb00199.x","article-title":"Metabolic syndrome in people with schizophrenia: a review","volume":"8","author":"De Hert","year":"2009","journal-title":"World Psychiatry"},{"key":"10.1016\/j.schres.2015.05.004_bb0050","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/mpr.322","article-title":"The METEOR study of diabetes and other metabolic disorders in patients with schizophrenia treated with antipsychotic drugs. I. Methodology","volume":"19","author":"De Hert","year":"2010","journal-title":"Int. J. Methods Psychiatr. Res."},{"issue":"1\u20133","key":"10.1016\/j.schres.2015.05.004_bb0075","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.schres.2008.04.017","article-title":"Glucose abnormalities in the siblings of people with schizophrenia","volume":"103","author":"Fernandez-Egea","year":"2008","journal-title":"Schizophr. Res."},{"issue":"1\u20133","key":"10.1016\/j.schres.2015.05.004_bb0080","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.schres.2007.10.002","article-title":"Parental history of type 2 diabetes in patients with nonaffective psychosis","volume":"98","author":"Fernandez-Egea","year":"2008","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2015.05.004_bb0085","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.psychres.2012.03.043","article-title":"Prevalence of metabolic syndrome in patients with schizophrenia in India","volume":"200","author":"Grover","year":"2012","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.schres.2015.05.004_bb0090","article-title":"Metabolic syndrome in antipsychotic na\u00efve patients with schizophrenia: pooled analysis of data from three Indian studies","author":"Grover","year":"2014","journal-title":"Early Interv. Psychiatry"},{"key":"10.1016\/j.schres.2015.05.004_bb0095","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1161\/01.CIR.0000133317.49796.0E","article-title":"Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines","volume":"110","author":"Grundy","year":"2004","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.schres.2015.05.004_bb0100","doi-asserted-by":"crossref","first-page":"575","DOI":"10.4088\/JCP.v64n0513","article-title":"Metabolic syndrome in patients with schizophrenia","volume":"64","author":"Heiskanen","year":"2003","journal-title":"J. Clin. Psychiatry"},{"issue":"4","key":"10.1016\/j.schres.2015.05.004_bb0105","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/01.pra.0000358312.99233.ef","article-title":"Waist circumference is the best anthropometric predictor for insulin resistance in nondiabetic patients with schizophrenia treated with clozapine but not olanzapine","volume":"15","author":"Henderson","year":"2009","journal-title":"J. Psychiatr. Pract."},{"key":"10.1016\/j.schres.2015.05.004_bb0110","author":"IDF Consensus IDF"},{"key":"10.1016\/j.schres.2015.05.004_bb0115","doi-asserted-by":"crossref","first-page":"74","DOI":"10.4088\/PCC.v06n0205","article-title":"Prevalence of metabolic syndrome in Hispanic and non-Hispanic patients with schizophrenia","volume":"6","author":"Kato","year":"2004","journal-title":"Prim. Care Comp. J. Clin. Psychiatry"},{"issue":"4","key":"10.1016\/j.schres.2015.05.004_bb0120","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/sj.ejcn.1602554","article-title":"Prevalence of the metabolic syndrome among Turkish adults","volume":"61","author":"Kozan","year":"2007","journal-title":"Eur. J. Clin. Nutr."},{"issue":"3","key":"10.1016\/j.schres.2015.05.004_bb0125","doi-asserted-by":"crossref","first-page":"227","DOI":"10.4103\/0253-7176.119471","article-title":"Metabolic syndrome in schizophrenia","volume":"35","author":"Malhotra","year":"2013","journal-title":"Indian J. Psychol. Med."},{"key":"10.1016\/j.schres.2015.05.004_bb0130","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.schres.2015.05.004_bb0135","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1093\/schbul\/sbr148","article-title":"Prevalence of metabolic syndrome and metabolic abnormalities in schizophrenia and related disorders \u2014 a systematic review and meta-analysis","volume":"39","author":"Mitchell","year":"2013","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2015.05.004_bb0140","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0140-6736(89)91392-5","article-title":"Family history of type 2 diabetes in schizophrenic patients","volume":"1","author":"Mukherjee","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.schres.2015.05.004_bb0145","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0920-9964(99)00191-7","article-title":"Mortality and causes of death in schizophrenia in Stockholm county, Sweden","volume":"45","author":"Osby","year":"2000","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2015.05.004_bb0150","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3109\/08039488.2011.621977","article-title":"Metabolic syndrome in schizophrenia: a comparative study of antipsychotic-free\/na\u00efve and antipsychotic-treated patients from India","volume":"66","author":"Pallava","year":"2012","journal-title":"Nord. J. Psychiatry"},{"key":"10.1016\/j.schres.2015.05.004_bb0155","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1176\/appi.ajp.160.2.284","article-title":"Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia","volume":"160","author":"Ryan","year":"2003","journal-title":"Am. J. Psychiatry"},{"issue":"1\u20133","key":"10.1016\/j.schres.2015.05.004_bb0160","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.schres.2008.02.013","article-title":"Are metabolic indices different between drug-na\u00efve first-episode psychosis patients and healthy controls","volume":"102","author":"Sengupta","year":"2008","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2015.05.004_bb0165","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1464-5491.2007.02092.x","article-title":"Impaired glucose tolerance in first-episode drug-naive patients with schizophrenia","volume":"24","author":"Spelman","year":"2007","journal-title":"Diabet. Med."},{"issue":"12","key":"10.1016\/j.schres.2015.05.004_bb0170","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1111\/j.1464-5491.2004.01361.x","article-title":"Association of simple anthropometric measures of obesity with visceral fat and the metabolic syndrome in male Caucasian and Indo-Asian subjects","volume":"21","author":"Valsamakis","year":"2004","journal-title":"Diabet. Med."},{"issue":"3","key":"10.1016\/j.schres.2015.05.004_bb0175","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/wps.20069","article-title":"A meta-analysis of cardio-metabolic abnormalities in drug na\u00efve, first-episode and multi-episode patients with schizophrenia versus general population controls","volume":"12","author":"Vancampfort","year":"2013","journal-title":"World Psychiatry"},{"key":"10.1016\/j.schres.2015.05.004_bb0180","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1176\/appi.ajp.2007.07020233","article-title":"Insulin and insulin-like growth factor-1 abnormalities in antipsychotic-naive schizophrenia","volume":"164","author":"Venkatasubramanian","year":"2007","journal-title":"Am. J. Psychiatry"},{"issue":"7","key":"10.1016\/j.schres.2015.05.004_bb0185","doi-asserted-by":"crossref","first-page":"997","DOI":"10.4088\/JCP.08m04508","article-title":"Metabolic risk factors in drug-naive patients with first-episode psychosis","volume":"70","author":"Verma","year":"2009","journal-title":"J. Clin. Psychiatry"}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996415002601?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996415002601?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,25]],"date-time":"2019-08-25T07:26:38Z","timestamp":1566717998000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996415002601"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":37,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S0920996415002601"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2015.05.004","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic syndrome in drug-na\u00efve and drug-free patients with schizophrenia and in their siblings","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2015.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}